TissueGen
Share
is the developer of award-winning and patent-protected ELUTE® fiber: a biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering.
12/09/2019
TissueGen‘s chief scientist and co-founder, Kevin Nelson, tells Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber.
Tackling drug delivery challenges with TissueGen’s implantable fibers | Drug Delivery Business TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How did TissueGen get its start? Nelson: In 1996, while faculty in biomedical engineering at The Unive...
12/09/2019
Biologics and fivers can advance nerve generation! TissueGen is at the forefront of this innovative work.
It takes some nerve: How biologics and fibres can advance nerve generation Dr. Kevin Nelson, founder and CSO, TissueGen explains how biologics and fibres could make for an entirely new approach to nerve generation, advanced drug delivery and tissue engineering.
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
2110 Research Row, Suite 330
Dallas, TX
75235
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
